Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

IMpella-Protected cArdiaC Surgery Trial (IMPACT)

NCT05529654 is registered in ClinicalTrials.gov with Abiomed Inc. as lead sponsor.

NCT NCT05529654
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05529654 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
IMpella-Protected cArdiaC Surgery Trial (IMPACT)
Lead sponsor
Abiomed Inc.
Phase
Not applicable
Overall status
Completed
Start date
September 21, 2023
Completion date
August 3, 2026
Enrollment
100 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

left ventricular dysfunction